1.Research advances on long-term outcomes of endoscopic submucosal dissection for early esophageal cancer
Chinese Journal of General Practitioners 2016;15(9):730-733
With the improvement of endoscopic technology,an increasing number of early esophageal cancer is diagnosed by gastroscopy.Regardless of the size or submucous fibrosis of esophageal cancer,endoscopic submucosal dissection (ESD) allows en bloc resection and histologically complete resection of the tumor.ESD has been recognized as an optimal treatment modality for early esophageal carcinoma.Currently,short-term curative effects of early esophageal cancer after ESD have been proved satisfactory,but the long-term outcomes remain unclear.This paper reviews the research advances about the long-term outcomes of ESD,and focuses on the postoperative stenosis,the recurrence,metastasis and survival rates of patients,to provide treatment reference for clinicians.
2.Therapeutic Observation of Electroacupuncture plus Puncturing the Thirteen Ghost Points for Diabetic Gastroparesis
Shanghai Journal of Acupuncture and Moxibustion 2015;(5):426-427
Objective To observe the clinical efficacy of electroacupuncture plus puncturing the thirteen ghost points in treating diabetic gastroparesis.Method Sixty patients with diabetic gastroparesis were randomized into a treatment group and a control group, 30 in each group. The treatment group was intervened by electroacupuncture plus puncturing the thirteen ghost points, while the control group was by electroacupuncture alone. The clinical efficacies were then compared.Result The total effective rate was 93.3% in the treatment group versus 83.3% in the control group, and the difference was statistically significant (P<0.05). Conclusion Electroacupuncture plus puncturing the thirteen ghost points is an effective approach in treating diabetic gastroparesis.
3.Arginine and repair of burn injury.
Chinese Journal of Burns 2005;21(4):244-246
Arginine
;
therapeutic use
;
Burns
;
therapy
;
Humans
;
Nutrition Therapy
;
Wound Healing
4.Retrospect and prospect.
Chinese Journal of Burns 2005;21(1):4-5
5.Some hot spots in the treatment of gastrointestinal stromal tumor
Cancer Research and Clinic 2010;22(2):74-75
Gastrointestinal stromal tumor (GIST) may be defined as mesenchymal tumors of the gastrointestinal tract,and the application of the tyrosine kinase inhibitor imatinib mesylate has changed the treatment style of the tumor.The surgical treatment is the only choice for the GIST patients before imatinib era,but now the individualized treatment combined with target therapy,surgery and laparoscope surery becomes the mainstay.The paper focus on the new development of preoperative biopsy,laparoscope surery,imatinib neoadjuvant and imatinib therapeutic effect evaluation in recent years.
8.Relationship between glutamine and the repair of burn trauma.
Chinese Journal of Burns 2003;19(4):193-194
Animals
;
Burns
;
drug therapy
;
metabolism
;
Glutamine
;
pharmacology
;
therapeutic use
;
Humans
;
Wound Healing
;
drug effects
9.Detection and Clinical Significance of Serum TSGF in Patients with Colorectal Carcinoma
Journal of Chinese Physician 2001;0(03):-
Objective To evaluate the clinical significance of serum tumor supplied group of factor (TSGF) in diagnosing colorectal carcinoma. Methods The TSGF concentration in the patients with colorectal carcinoma, with colorectal polyp and healthy subjects were retrospectively reviewed. Results The TSGF concentration in the colorectal carcinoma patients was significantly higher than that in the colorectal polyp patients (P
10.Relationship between the expression of EGF, EGFR and PCNA with clinicopathological characteristics in human colorectal carcinoma
Chinese Journal of General Surgery 1997;0(04):-
Objective To evaluate the relationship between the expression of EGF, EGFR and PCNA with the clinicopathological characteristics in human colorectal carcinoma. Methods Immunohistochemistry was used to examine the expression of EGF, EGFR and PCNA in 50 specimens of colorectal carcinoma and 10 specimens of normal colorectal tissue. Results In cancer specimens,the expression of EGF and EGFR were 76.07% and 84.15% respectively, but in normal colorectal tissue were no expression of EGF and EGFR (P